Viewing Study NCT00369434


Ignite Creation Date: 2025-12-25 @ 2:22 AM
Ignite Modification Date: 2025-12-31 @ 10:25 AM
Study NCT ID: NCT00369434
Status: COMPLETED
Last Update Posted: 2007-06-01
First Post: 2006-08-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Postmenopausal Women
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module